AdvisorShares Investments LLC trimmed its stake in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 18.6% in the fourth quarter, HoldingsChannel reports. The firm owned 13,362 shares of the biopharmaceutical company’s stock after selling 3,053 shares during the quarter. AdvisorShares Investments LLC’s holdings in Sage Therapeutics were worth $290,000 as of its most […]

Related Keywords

China , Zurcher Kantonalbank Zurich Cantonalbank , Robertw Baird , Advisorshares Investments , China Universal Asset Management Co , Exchange Commission , Sage Therapeutics Inc , Goldman Sachs Group , Nasdaq , Quest Partners , Scotiabank , Sage Therapeutics , Free Report , Shares Investments , Universal Asset Management , Kantonalbank Zurich Cantonalbank , Get Free Report , Visit Holdingschannel , Sage Therapeutics Daily ,